Showing results (51-60 of 84) with videos related to

Sort By:
Pageof 9
International Journal of Clinical Oncology|June 28, 2018
Changes in programmed death ligand 1 expression in non-small cell lung cancer patients who received anticancer treatmentsShota Omori, Hirotsugu Kenmotsu, Masato Abe, et al.
Investigational New Drugs|March 5, 2020
Clinical and radiation dose-volume factors related to pneumonitis after treatment with radiation and durvalumab in locally advanced non-small cell lung cancerHiroto Inoue, Akira Ono, Takanori Kawabata, et al.
Journal of Geriatric Oncology|July 13, 2024
Effect of polypharmacy on the outcomes of older patients with advanced non-small-cell lung cancer treated with PD-1/PD-L1 inhibitors: A retrospective cohort studyNoboru Morikawa, Tateaki Naito, Meiko Morita, et al.
Thoracic Cancer|October 24, 2023
Safety and efficacy of amrubicin with primary prophylactic pegfilgrastim as second-line chemotherapy in patients with small cell lung cancerMotoki Sekikawa, Haruyasu Murakami, Meiko Morita, et al.
Cancer Science|October 24, 2020
Proposing synchronous oligometastatic non-small-cell lung cancer based on progression after first-line systemic therapyTaichi Miyawaki, Kazushige Wakuda, Hirotsugu Kenmotsu, et al.
Investigational New Drugs|October 11, 2021
Prognostic impact of pneumonitis after durvalumab therapy in patients with locally advanced non-small cell lung cancerAri Nishimura, Akira Ono, Kazushige Wakuda, et al.
BMC Cancer|November 20, 2021
Association between oligo-residual disease and patterns of failure during EGFR-TKI treatment in EGFR-mutated non-small cell lung cancer: a retrospective studyTaichi Miyawaki, Hirotsugu Kenmotsu, Hiroaki Kodama, et al.
Lung Cancer (Amsterdam, Netherlands)|November 28, 2020
Efficacy of pembrolizumab in patients with brain metastasis caused by previously untreated non-small cell lung cancer with high tumor PD-L1 expressionKazushige Wakuda, Michitoshi Yabe, Hiroaki Kodama, et al.
Thoracic Cancer|July 30, 2024
Exploring the relationship between anorexia and therapeutic efficacy in advanced lung cancer treatment: a retrospective studyKosei Doshita, Tateaki Naito, Suguru Matsuda, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 28, 2026
Weight change and impact on prognosis in patients with advanced non-small cell lung cancer with concomitant diabetes mellitus treated with sglt2 inhibitorsNoboru Morikawa, Tateaki Naito, Yuta Okawa, et al.
Pageof 9